Once-daily treatment of ADHD with guanfacine: patient implications

References

• ArnoldLEPsychoactive Medications for ADHD: Drugs, Doses, and EffectsContemporary Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder20022PennsylvaniaHandbooks in Health Care Co9899
   Google Scholar
• AokiCVenkatesanCGoC-GFormanRCellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axonsCerebral Cortex19988269779617922
   PubMed Web of Science ®Google Scholar
• ArnstenAFTCaiJXGoldman-RakicPSThe alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effectsJ Neurosci198884287982903226
   PubMed Web of Science ®Google Scholar
• ArnstenAFLiBMNeurobiology of executive functions: catecholamine influences on prefrontal cortical functionsBiol Psychiatry20065713778415950011
   PubMed Web of Science ®Google Scholar
• ArnstenAFTSteereJCHuntRDThe contribution of alpha-2 noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance to Attention Deficit Hyperactivity DisorderArch Gen Psychiatry199653448558624188
   PubMed Web of Science ®Google Scholar
• Aston-JonesGRajkowskiJCohenJLocus coeruleus and regulation of behavioral flexibility and attentionProg Brain Res20001261658211105646
   PubMed Web of Science ®Google Scholar
• AveryRAFranowiczJSStudholmeCThe alpha-2A-adenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory taskNeuropsychopharmacology200023240910942848
   PubMed Web of Science ®Google Scholar
• BellgroveMAHawiZGillMRobertsonIHThe cognitive genetics of attention deficit hyperactivity disorder (ADHD): Sustained attention as a candidate phenotypeCortex2006428384517131588
   PubMed Web of Science ®Google Scholar
• BiedermanJArnstenAFFaraoneSVNew developments in the treatment of ADHDJ Clin Psychiatry2006671485916426101
   PubMed Web of Science ®Google Scholar
• BoellnerSWPennickMFiskeKPharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorderPharmacotherapy20072712536217723079
   PubMed Web of Science ®Google Scholar
• Boon-yasidhiVKimYSScahillLAn open-label, prospective study of guanfacine in children with ADHD and tic disordersJ Med Assoc Thai200588Suppl 8S1566216856436
   PubMedGoogle Scholar
• BoremanCDArnoldLEHallucations Associated with Initiation of GuanfacineJ Am Acad Child Adolesc Psychiatry20033411406
   Google Scholar
• CastellanosFXLeePPSharpWDevelopmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorderJAMA20022881740812365958
   PubMed Web of Science ®Google Scholar
• Center for Disease ControlNational Center on Birth Defects and Developmental Disabilities2005 http://www.cdc.gov
   Google Scholar
• ChappellPBRiddleMAScahillLGuanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experienceJ Am Acad Child Adolesc Psychiatry199534114067559307
   PubMed Web of Science ®Google Scholar
• CohnLMCaliendoGCGuanfacine use in children with attention deficit hyperactivity disorderAnn Pharmacother19973191899220058
   PubMed Web of Science ®Google Scholar
• ConnersCKCasatCDGualtieriCDBupropion hydrochloride in attention deficit disorder with hyperactivityJ Am Acad Child Adolesc Psychiatry1996351314218885585
   PubMed Web of Science ®Google Scholar
• CornishLAGuanfacine hydrochloride: a centrally acting antihypertensive agentClin Pharm19887187973281788
   PubMedGoogle Scholar
• CoupryILachaudVPodevinRADifferent affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptorsAm J Hypertens19892468702569318
   PubMed Web of Science ®Google Scholar
• EngbergGErikssonEEffects of alpha-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated ratsNaunyn-Schmiedebergs Arch Pharmacol199134347271652697
   PubMed Web of Science ®Google Scholar
• FullerMASajatovicMDDrug Information Handbook for Psychiatry2002Hudson (Cleveland)Lexi-comp
   Google Scholar
• Goldman-RakicPSPlumFCircuitry of the primate prefrontal cortex and the regulation of behavior by representational memoryHandbook of Physiology, The Nervous System, Higher Functions of the Brain1987BethesdaAmerican Physiological Society373417
   Google Scholar
• HorriganJPBarnhillLJDoes guanfacine trigger mania in children?J Child Adolesc Psychopharmacol19988149509730081
   PubMed Web of Science ®Google Scholar
• HuntRDArnstenAFAsbellMDAn open trial of guanfacine in the treatment of attention-deficit hyperactivity disorderJ Am Acad Child Adolesc Psychiatry1995345047860456
   PubMed Web of Science ®Google Scholar
• JensonPSGaricaJA AGliedSCost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children With ADHDAm J Psychiatry200516216283616135621
   PubMed Web of Science ®Google Scholar
• KielingCGenroJPHutzMHThe -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHDAm J Med Genet B Neuropsychiatr Genet2008147B4859018081028
   PubMed Web of Science ®Google Scholar
• KisickiJFiskeKLyneAPhase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 yearsClin Ther20072919677918035196
   PubMed Web of Science ®Google Scholar
• LopezFAADHD: new pharmacological treatments on the horizonJ Dev Behav Pediatr200627410617041279
   PubMed Web of Science ®Google Scholar
• MaC-LArnstenAFTLiB-MLocomotor hyperactivity induced by blockade of prefrontal cortical alpha-2-adrenoceptors in monkeysBiological Psychiatry200557192515652880
   PubMed Web of Science ®Google Scholar
• MaC-LQiX-LPengJ-YSelective deficit in no-go performance induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeysNeuroreport2003141013612802193
   PubMed Web of Science ®Google Scholar
• MacDonaldEKobilkaBKScheininMGene targeting – Homing in on alpha-2-adrenoceptor subtype functionTrends in Pharmacolog Sci19971821119
   PubMed Web of Science ®Google Scholar
• MaoZ-MArnstenAFTLiB-MLocal infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeysBiol Psychiatry19994612596510560031
   PubMed Web of Science ®Google Scholar
• MelmedRDPatelAKonowJEfficacy and safety of guanfacine extended release for ADHD treatmentAACAP Presentation2006Shire Development, Inc
   Google Scholar
• MichelsonDAllenAJBusnerJOnce-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled studyAm J Psychiatry2002159189690112411225
   PubMed Web of Science ®Google Scholar
• Mosqueda-GarciaRGuanfacine: a second generation alpha 2-adrenergic blockerAm J Med Sci19902997361967513
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health http://www.nimh.nih.gov
   Google Scholar
• NewcornJHSchulzKHarrisonMAlpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in childrenPediatr Clin North Am199845109922 viii9884677
   PubMed Web of Science ®Google Scholar
• PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20074689492117581453
   PubMed Web of Science ®Google Scholar
• PoseyDJPuntneyJISasherTMGuanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 casesJ Child Adolesc Psychopharmacol2004142334115319020
   PubMed Web of Science ®Google Scholar
• RamosBStarkDVerduzcoLAlpha-2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animalsLearning and Memory200613770617101879
   PubMed Web of Science ®Google Scholar
• SaraSJHerve-MinvielleAInhibitory influence of frontal cortex on locus coeruleusProc Nat Acad Sci U S A19959260326
   PubMed Web of Science ®Google Scholar
• ScahillLAmanMGMcDougleCJA prospective open trial of guanfacine in children with pervasive developmental disordersJ Child Adolesc Psychopharmacol2006165899817069547
   PubMed Web of Science ®Google Scholar
• ScahillLBarloonLFarkasLAlpha-2 agonists in the treatment of attention deficit hyperactivity disorderJ Child Adolesc Psychiatr Nurs1999121687310876518
   PubMedGoogle Scholar
• ScahillLChappellPBKimYSA placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorderAm J Psychiatry200115810677411431228
   PubMed Web of Science ®Google Scholar
• SeidmanLJValeraEMMakrisNDorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imagingBiol Psychiatry20066010718016876137
   PubMed Web of Science ®Google Scholar
• SorkinEHeelRGuanfacine: A review of its pharmacodynamics and pharmacokinectic properties, and therapeutic efficacy in the treatment of hypertensionDrugs198631301363519177
   PubMed Web of Science ®Google Scholar
• SwartzBEKovalikEThomasKThe effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsyNeuropsychopharmacology2000232637510942850
   PubMed Web of Science ®Google Scholar
• SwearingenDPennickMShojaeiAA phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adultsClin Ther2007296172517617285
   PubMed Web of Science ®Google Scholar
• TaylorFBRussoJComparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorderJ Clin Psychopharmacol200121223811270920
   PubMed Web of Science ®Google Scholar
• U’PrichardDCBechtelWDRouotBMMultiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamineMol Pharmacol197916476039248
   PubMed Web of Science ®Google Scholar
• UhlenSPorterACNeubigRRThe novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptorsJ Pharmacol Exp Ther19942711558657996470
   PubMed Web of Science ®Google Scholar
• WangMRamosBPPaspalasCDAlpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortexCell200712939741017448997
   PubMed Web of Science ®Google Scholar
• WeissMTannockRKratochvilCA randomized, placebo-controlled study of once-daily atomoxetinein the school setting in children with ADHDJ Am Acad Child Adolesc Psychiatry2005446475515968233
   PubMed Web of Science ®Google Scholar
• WolraichMLGreenhillLLPelhamPRandomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorderPediatrics20011088839211581440
   PubMed Web of Science ®Google Scholar